Prestige Consumer Healthcare (FRA:PBV) Market Cap : €3,225 Mil (As of May. 08, 2024)

View and export this data going back to 2005. Start your Free Trial

What is Prestige Consumer Healthcare Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Prestige Consumer Healthcare's share price for the quarter that ended in Dec. 2023 was €55.5. Prestige Consumer Healthcare's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 50 Mil. Therefore, Prestige Consumer Healthcare's market cap for the quarter that ended in Dec. 2023 was €2,756 Mil.

Prestige Consumer Healthcare's quarterly market cap increased from Jun. 2023 (€2,700 Mil) to Sep. 2023 (€2,704 Mil) and increased from Sep. 2023 (€2,704 Mil) to Dec. 2023 (€2,756 Mil).

Prestige Consumer Healthcare's annual market cap increased from Mar. 2021 (€1,847 Mil) to Mar. 2022 (€2,413 Mil) and increased from Mar. 2022 (€2,413 Mil) to Mar. 2023 (€2,832 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Prestige Consumer Healthcare's Enterprise Value for Today is €4,293 Mil.

Prestige Consumer Healthcare Market Cap Historical Data

The historical data trend for Prestige Consumer Healthcare's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige Consumer Healthcare Market Cap Chart

Prestige Consumer Healthcare Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Market Cap

Get a 7-Day Free Trial

1,345.74

1,652.84

1,846.71

2,413.39

2,832.44

Prestige Consumer Healthcare Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Market Cap	Get a 7-Day Free Trial															2,956.38	2,832.44	2,699.93	2,703.80	2,755.52

Competitive Comparison of Prestige Consumer Healthcare's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Prestige Consumer Healthcare's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prestige Consumer Healthcare's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Prestige Consumer Healthcare's Market Cap distribution charts can be found below:

* The bar in red indicates where Prestige Consumer Healthcare's Market Cap falls into.

Prestige Consumer Healthcare Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Prestige Consumer Healthcare's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as

Market Cap (A: Mar. 2023 )	=	Share Price (A: Mar. 2023 )	*	Shares Outstanding (EOP) (A: Mar. 2023 )
	=	€57	*	49.692
	=	€2,832

Prestige Consumer Healthcare's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	€55.5	*	49.649
	=	€2,756

Prestige Consumer Healthcare (FRA:PBV) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Prestige Consumer Healthcare Market Cap Related Terms

Thank you for viewing the detailed overview of Prestige Consumer Healthcare's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Prestige Consumer Healthcare (FRA:PBV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Prestige Consumer Healthcare Inc (FRA:PBV) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

PBH:USA

Address

660 White Plains Road, Tarrytown, NY, USA, 10591

Website

https://www.prestigebrands.com

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Prestige Consumer Healthcare (FRA:PBV) Headlines

No Headlines